$70.30
RX Prescription is needed for this product.
Aivlosin WSG Water Soluble Granules is a novel therapeutic antibiotic, setting the new standard for cost-effective control of ileitis.
Product Description: For control of procine proliferative enteropathy (PPE) associated with Lawsonia intracellularis in pigs.
Aivlosin is a water-soluble antibiotic for oral use by administration in the drinking water. The product contains 62.5% w/w tylvalosin (as tylvalosin tartrate), a macrolide antibiotic. Labled for 0 day withdrawal.
$167.65
RX Prescription is needed for this product.
Aivlosin WSG Water Soluble Granules is a novel therapeutic antibiotic, setting the new standard for cost-effective control of ileitis.
Product Description: For control of procine proliferative enteropathy (PPE) associated with Lawsonia intracellularis in pigs.
Aivlosin is a water-soluble antibiotic for oral use by administration in the drinking water. The product contains 62.5% w/w tylvalosin (as tylvalosin tartrate), a macrolide antibiotic. Labled for 0 day withdrawal.
$61.02
Rx – Script Form Required
Baytril Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Dosage: Baytril may be administered as a single dose for one day (cattle and swine) or for multiple days (cattle) of therapy. Selection of the appropriate dose and duration of therapy should be based on an assessment of the severity of disease, pathogen susceptibility and clinical response.
$132.08
Rx – Script Form Required
Baytril Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Dosage: Baytril may be administered as a single dose for one day (cattle and swine) or for multiple days (cattle) of therapy. Selection of the appropriate dose and duration of therapy should be based on an assessment of the severity of disease, pathogen susceptibility and clinical response.
$294.70
Indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK) and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Dosage: The recommended dosage of is 2.5 mg per kg (1.1 ml per 100 lbs) body weight, given SQ in the neck. Do not administer more than 20 ml per injection site in cattle. Do not administer more than 5 ml per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal.
$700.55
Indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK) and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Dosage: The recommended dosage of is 2.5 mg per kg (1.1 ml per 100 lbs) body weight, given SQ in the neck. Do not administer more than 20 ml per injection site in cattle. Do not administer more than 5 ml per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal.
$55.90
RX – PRESCRIPTION NEEDED FOR THIS PRODUCT.
Enroflox 100 is a sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.
Therapeutic treatment with Enroflox 100 is administered as a single dose for one day (swine) or for multiple days (cattle) of therapy. Each mL of Enroflox 100 contains 100 mg of enrofloxacin. Excipients are L-arginine base 200 mg, n-butyl alcohol 30 mg, benzyl alcohol (as a preservative) 20 mg and water for injection q.s.Uses
Cattle: Enroflox 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle.
Swine: Enroflox 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis.
Dosage & Administration
Enroflox 100 is administered as a single dose for one day (swine) or for multiple days (cattle) of therapy.
Withdrawal Period
Animals intended for human consumption must not be slaughtered within 28 days from the last treatment. This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been
established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.Swine: Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.
$110.54
RX SCRIPT NEEDED FOR THIS PRODUCT
Enroflox 100 is a sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.
Therapeutic treatment with Enroflox 100 is administered as a single dose for one day (swine) or for multiple days (cattle) of therapy. Each mL of Enroflox 100 contains 100 mg of enrofloxacin. Excipients are L-arginine base 200 mg, n-butyl alcohol 30 mg, benzyl alcohol (as a preservative) 20 mg and water for injection q.s.Uses
Cattle: Enroflox 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle.
Swine: Enroflox 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis.
Dosage & Administration
Enroflox 100 is administered as a single dose for one day (swine) or for multiple days (cattle) of therapy.
Withdrawal Period
Animals intended for human consumption must not be slaughtered within 28 days from the last treatment. This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been
established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.Swine: Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.
$35.37
CALL YOUR VETERINARIAN FOR PRICING
ITEM CANNOT SHIP TO CALIFORNIA
FDA approved product (NADA 141-360)
Equisul-SDT®
(Sulfadiazine/Trimethoprim)
Contains 400 mg combined active ingredient
(333 mg sulfadiazine and 67 mg of trimethoprim)Product Features
• EQUISUL-SDT is proven effective in horses
for the treatment of lower respiratory tract
infections caused by susceptible strains of
Streptococcus equi subsp. zooepidemicus
in controlled field trials.
• EQUISUL-SDT safety was demonstrated in
a controlled study in horses at 1X, 3X and
5X the recommended dose for 30 days.
• Easy-to-use liquid formulation.
• Significantly higher bioavailability on a
mg-to-mg basis compared to an existing
approved paste product, based on a
pharmacokinetic crossover study.
• Low incidence of side effects in our controlled
safety studies.
